INHIBIKASE THERAPEUTICS INC (IKT) Institutional Ownership and Insiders Activity
INHIBIKASE THERAPEUTICS INC (IKT) is widely held by institutional investors, with 105 firms reporting positions valued at approximately $226.21M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Sands Capital Alternatives, Llc is the largest disclosed holder, reporting approximately $26.43M in IKT holdings in its latest filing.
Institutional Holders
105
Total Reported Value
$226.21M
Largest Holder
Sands Capital Alternatives, Llc
Largest Position
$26.43M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
20
Funds Exiting Positions
18
Top Institutional Owners
View allInvestorReported Balance
- Sands Capital Alternatives, Llc$26.43M
- Soleus Capital Management, L.P.$22.08M
- Trails Edge Capital Partners, Lp$18.37M
- Fairmount Funds Management Llc$17.51M
- Blackrock, Inc.$15.77M
Related IKT Institutional Insights:
- IKT 13F Institutional Holders
- IKT Superinvestors
- IKT Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- IKT Insider Trading & SEC Form 4 Activity
- IKT Articles
- Top Institutional Investor Stock Rankings